Residual DNA Testing Market to Reach USD 0.37 Billion by 2030
The global Residual DNA Testing Market is projected to grow from USD 0.28 billion in 2025 to USD 0.37 billion by 2030, registering a CAGR of 6.0% during the forecast period. The market’s growth is primarily driven by increasing regulatory approvals for biologics and biosimilars, stringent product safety and quality requirements, and rising investments in advanced therapeutic...
How Residual DNA Testing Is Becoming Essential to Advancing Biopharmaceutical Development
The residual DNA testing market is undergoing significant growth, driven by rising regulatory approvals for biologics and biosimilars, along with increased global investments in research and development. As of 2024, the market is heavily shaped by regulatory mandates that require manufacturers to demonstrate the safety, purity, and efficacy of biopharmaceutical products. For executives across pharmaceuticals,...